All Regulation articles – Page 31
-
Business
Pineapple gel approved for burns
EU regulators approve NexoBrid gel from MediWound for removal of scab tissue
-
Business
Myelofibrosis drug approved in EU
Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow
-
Business
Alzheimer's drug flops in Phase III
Solanezumab from Eli Lilly missed the cognitive and functional primary endpoints of the trials
-
Business
Generic Actos approved
Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets
-
Business
Bapineuzunab dropped
Development for the Alzheimer’s treatment stopped after clinical tests
-
-
Business
New cystic fibrosis drug in EU
Ivacaftor works by helping defective proteins function more normally
-
Business
New US chemical rules edge nearer
Chemical manufacturers would have to produce safety data for their products
-
Business
Drugs top EU counterfeit imports
In 2011, medicines topped the list of fake products entering the EU
-
Business
UK urged to clean up London air
Think tank says ‘invisible’ pollution is public health problem comparable to obesity and alcohol
-
Business
First HIV drug approved as prevention
Truvada tablets can reduce the risk of infection for an HIV-negative person
-
Business
GSK drug shines in HIV trial
HIV–Aids drug candidate dolutegravir outperformed Atripla tablets in Phase III
-
Business
Brazil hits BASF with worker payout
BASF and Shell have been ordered to pay BRL1 billion (£300 million) to compensate employees for damage to their health
-
OpinionProtecting the spirit of competition
Keeping sport clean requires a constant, concerted effort that carries on long after the race is run, says Michael Stow
-
Business
US GM labelling rule quashed
The rule would have authorised state governments to enforce GM labels on food products
-
Business
ECHA finishes first combo review
The European Chemical Agency has looked at a group of phthalates as a combination when considering risks associated with exposure
-
Business
Good signs for Merck & Co insomnia pill
Suvorexant switches off wakefulness to help patients drop off quicker and stay asleep longer
-
Business
More testing needed for ridaforolimus
Marketing approval for anti-cancer drug ridaforolimus has been held up in the US
-
Business
Three pronged approach puts brakes on US breast cancer
US approval for anti-HER2 therapy Perjeta (pertuzumab) against breast cancer